Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00346515 · ClinicalTrials.gov registry record · NA
EPIC US Feasibility Study: Use of the FiberNet® Emboli Protection Device in Carotid Artery Stenting
A NA study, sponsored by Lumen Biomedical.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT00346515 is a NA study that has completed, run by Lumen Biomedical. The registered enrollment target is 30 participants.
The verdict
NCT00346515, a NA study, has completed, sponsored by Lumen Biomedical.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
Multicenter, prospective, feasibility study designed to demonstrate the performance and safety of the Lumen Biomedical, Inc. FiberNet™ Embolic Protection System as an adjunctive device during carotid artery percutaneous intervention using the Guidant Acculink carotid stent in high surgical risk patients.
Interventions
- DEVICE FiberNet Emboli Protection System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2006-06 |
| Est. Completion | 2008-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00346515
The ClinicalTrials.gov registry entry for NCT00346515 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lumen Biomedical, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FiberNet Emboli Protection System is the first listed.
NCT00346515 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00346515 about?
NCT00346515 is a clinical study titled "EPIC US Feasibility Study: Use of the FiberNet® Emboli Protection Device in Carotid Artery Stenting". Multicenter, prospective, feasibility study designed to demonstrate the performance and safety of the Lumen Biomedical, Inc. FiberNet™ Embolic Protection System as an adjunctive device during carotid artery percutaneous intervention using the Guidant Acculink carotid stent in high surgical risk pati...
What is the current status of trial NCT00346515?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2006-06. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00346515?
The interventions under investigation include: FiberNet Emboli Protection System (DEVICE).
Who is sponsoring clinical trial NCT00346515?
This trial is sponsored by Lumen Biomedical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.